Two drug companies have now reported highly successful results from phase III trials of COVID-19 vaccines. On November 18 Pfizer and partner BioNTech said their vaccine was 95 percent effective at preventing the disease, based on full trial results. Two days earlier Moderna reported its vaccine was 94.5 percent effective, based on interim data.
It’s probably not exactly what President Donald Trump meant when he borrowed the historic jingoistic slogan “America First” for his administration, but since early in the global COVID-19 pandemic, the U.S. has consistently held the Number One spot in coronavirus cases and deaths. It took less than two months for these numbers to grow from 200,000 to a mind-boggling 250,000 now.
Operation Warp Speed, a Trump administration initiative to manufacture COVID-19 vaccines as fast as possible, should be lauded as a successful endeavour in what has otherwise been a poor effort to deal with the coronavirus, experts say. "No doubt, Operation Warp Speed is a huge success," said Tinglong Dai, associate professor of Operations Management and Business Analytics at Johns Hopkins University Carey Business School in Baltimore.
Reports of spiking COVID-19 cases and related fatalities have been met with recent news of extremely promising vaccines developed by Pfizer and Moderna. With the two offerings promising 90 and 95 percent effectiveness against the virus, respectively, attention now turns to mass production and, more importantly, mass distribution. According to Anna Nagurney, Ph.D., Director of the Virtual Center for Supernetworks and professor at the Department of Operations and Information Management at the University of Massachusetts, distribution is where the biggest challenges lie.
With COVID-19 cases rising across the country, the need for a safe and reliable vaccine is increasing. Both Pfizer and Moderna have announced vaccine trials with more than 90% effectiveness. Creating vaccines and getting federal approval are only the first hurdles which are followed by finding ways to transport the highly-perishable vaccines to millions of Americans.
Ashley Smith
Public Affairs Coordinator
INFORMS
Catonsville, MD
[email protected]
443-757-3578
An audio journey of how data and analytics save lives, save money and solve problems.
Cutting-edge chips, especially those designed to power emerging AI applications, tend to receive the most attention in the media and generate the most excitement. However, so-called “legacy” chips are just as important — if not more — to our daily lives.
A number of startups and cloud service providers are starting to offer tools for monitoring, evaluating, and correcting problems with generative AI in the hope of eliminating errors, hallucinations, and other systemic problems associated with this technology.
Tariffs could raise the cost of medical care and prescription drugs for people in the U.S.
New findings from a team of renowned researchers calls for transparency and rigorous oversight of the U.S. Medicare Advantage (MA) program, the United States' largest healthcare capitation program.
Dockworkers on the East and Gulf coasts could go on strike again in less than two weeks if they don’t reach a contract agreement with ports and shippers. Talks are set to resume next week, according to Bloomberg. The main sticking point between the two sides? Automation.
LONDON, Dec 30 (Reuters) - Chemicals factories founded or owned by some of Russia's wealthiest men are supplying ingredients to plants that manufacture explosives used by Moscow's military during the war in Ukraine, an analysis of railway and financial data shows.
Billionaire investor Mark Cuban's question to Representative Matt Gaetz, a Florida Republican, on energy costs took off on social media on Saturday.
Florida lawmakers have banned wind turbines off its shores and near the coast, saying the bill is meant to protect wildlife and prevent noise.